Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Nils Tore, Vethe"'
Autor:
Trine Lauritzen, John Munkhaugen, Stein Bergan, Elise Sverre, Kari Peersen, Sofia Lindahl, Einar Husebye, Nils Tore Vethe
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 10, Pp n/a-n/a (2024)
Abstract Statin‐associated muscle symptoms are frequently reported and often lead to discontinuation of statin therapy with an increased risk of cardiovascular events. In vitro studies suggest that statin‐mediated inhibition of the mevalonate pat
Externí odkaz:
https://doaj.org/article/5b65608158ed44b3a3a0003acb6a99f0
Autor:
Trine Lauritzen, John Munkhaugen, Stein Bergan, Kari Peersen, Anja Camilla Svarstad, Anders M. Andersen, Jens Pahnke, Einar Husebye, Nils Tore Vethe
Publikováno v:
Atherosclerosis Plus, Vol 55, Iss , Pp 31-38 (2024)
Background and aims: Statin-associated muscle symptoms (SAMS) is a prevalent cause of statin discontinuation. It is challenging and time-consuming for clinicians to assess whether symptoms are caused by the statin or not, and diagnostic biomarkers ar
Externí odkaz:
https://doaj.org/article/f98394738ee04db2a3ec9c22ef5ac108
Autor:
Kari Peersen, John Munkhaugen, Elise Sverre, Oscar Kristiansen, Morten Fagerland, Nils Tore Vethe, Joep Perk, Einar Husebye, Toril Dammen
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background To compare clinical and psychological factors among patients with self-perceived statin-associated muscle symptoms (SAMS), confirmed SAMS, and refuted SAMS in coronary heart disease patients (CHD). Methods Data were obtained from
Externí odkaz:
https://doaj.org/article/2fd685e366b148b7b0a08325c2da3665
Autor:
Trine Lauritzen, John Munkhaugen, Kari Peersen, Oscar Kristiansen, Elise Sverre, Shane D. Nebauer, Maja Villseth, Anders M. Andersen, Anja Camilla Svarstad, Elena Prunés Jensen, Stein Bergan, Einar Husebye, Nils Tore Vethe
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:887-895
Self-perceived statin-associated muscle symptoms (SAMS) are prevalent, but only a minority is drug-dependent. Diagnostic biomarkers are not yet identified. The local statin exposure in skeletal muscle tissue may correlate to the adverse effects. We a
Autor:
Nils Tore, Vethe, Einar, Husebye, Anders M, Andersen, Stein, Bergan, Oscar, Kristiansen, Morten W, Fagerland, John, Munkhaugen
Publikováno v:
Therapeutic Drug Monitoring. 44:558-567
Poor statin adherence remains a public health concern associated with adverse outcomes. We evaluated the use of pharmacokinetic measurements to monitor adherence to simvastatin in patients with coronary heart disease (CHD).Eighteen patients with CHD
Publikováno v:
Cell Transplantation, Vol 28 (2019)
Adoptive transfer of autologous polyclonal regulatory T cells (Tregs) is a promising option for reducing graft rejection in allogeneic transplantation. To gain therapeutic levels of Tregs there is a need to expand obtained cells ex vivo, usually in t
Externí odkaz:
https://doaj.org/article/a8d91b6101374785b97a8bea5df9d8d0
Autor:
Ragnhild Heier Skauby, Marte Theie Gustavsen, Anders Mikal Andersen, Anna Bjerre, Nils Tore Vethe, Anders Åsberg, Karsten Midtvedt, Stein Bergan
Publikováno v:
Therapeutic Drug Monitoring. 43:247-255
BACKGROUND Prednisolone (PL) is a standard component of most immunosuppressive protocols after solid organ transplantation (Tx). Adverse effects are frequent and well known. The aim of this study was to characterize the pharmacokinetics (PKs) of PL a
Autor:
T Lauritzen, JM John Munkhaugen, KP Kari Peersen, ES Elise Sverre, OK Oscar Kristiansen, EPJ Elena Prunes Jensen, SB Stein Bergan, EH Einar Husebye, NTV Nils Tore Vethe
Publikováno v:
European Journal of Preventive Cardiology. 29
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Vestre Viken Hospital Trust Background Statin-associated muscle symptoms (SAMS) cover a broader range of clinical presentations, with normal or mildly eleva
Autor:
Nils Tore Vethe, Ida Robertsen, Brenda C. M. de Winter, Birgit C. P. Koch, Mercè Brunet, Pierre Wallemacq, Florian Lemaitre, Amedeo Denicolo, Teun van Gelder, Dennis A. Hesselink, Stein Bergan, Raman Venkataramanan, Antonio D'Avolio, Camille Tron
Publikováno v:
Therapeutic Drug Monitoring, 42(5), 665-670. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2020, 42 (5), pp.665-670. ⟨10.1097/FTD.0000000000000780⟩
Therapeutic Drug Monitoring, 2020, 42 (5), pp.665-670. ⟨10.1097/FTD.0000000000000780⟩
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2020, 42 (5), pp.665-670. ⟨10.1097/FTD.0000000000000780⟩
Therapeutic Drug Monitoring, 2020, 42 (5), pp.665-670. ⟨10.1097/FTD.0000000000000780⟩
Background Therapeutic drug monitoring (TDM) of the two calcineurin inhibitors (CNIs), tacrolimus (TAC) and cyclosporine A (CsA), has resulted in improvements in the management of patients who have undergone solid organ transplantation. As a result o
Autor:
Nils Tore Vethe, Marte Theie Gustavsen, Ida Robertsen, Karsten Midtvedt, Stein Bergan, Jean Debord, Jean-Baptiste Woillard, Anders Åsberg, Rolf Anton Klaasen
Publikováno v:
Clinical and Translational Science
Therapeutic drug monitoring (TDM) is mandatory for the immunosuppressive drug tacrolimus (Tac). For clinical applicability, TDM is performed using morning trough concentrations. With recent developments making tacrolimus concentration determination p